The association of deamidation of Bcl-xL and translocation of Bax to the mitochondria through activation of JNK in the induction of apoptosis by treatment with GSH-conjugated DXR

被引:16
作者
Asakura, Tadashi [1 ]
Maeda, Kazuhiro [1 ]
Omi, Hiroko [1 ]
Matsudaira, Hiroshi [1 ]
Ohkawa, Kiyoshi [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Biochem, Minato Ku, Tokyo 1058461, Japan
关键词
Bcl-xL deamidation; Bax; JNK; apoptosis; GSH-conjugated DXR;
D O I
10.3892/ijo_00000020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the induction of apoptosis via deamidation of Bcl-xL and translocation of Bax to the mitochondria by treatment with GSH-DXR. GSH-DXR treatment of HepG2 cells, which did not express GST P1-1, exhibited deamidation of Bcl-xL, and the degree of deamidation was related to the activation of caspase-3. Overexpression of GST P1-1 in HepG2 cells decreased both the Bcl-xL deamidation and caspase-3 activation induced by treatment with GSH-DXR. Bcl-xL deamidation and caspase-3 activation were also suppressed by co-treatment with SP600125, a specific inhibitor of JNK activity. Overexpression of wild-type Bcl-xL in HepG2 decreased GSH-DXR-induced apoptosis although deamidation was observed. However, expression of the deamidated mutant of Bcl-xL, in which aspartic acid was substituted for both arginine 52 and 66 (N52,66D-Bcl-xL), exhibited high sensitivity for the induction of apoptosis. Expression of the Bcl-xL mutant, in which alanine was substituted for both arginine 52 and 66 (N52,66A-Bcl-xL), suppressed deamidation and showed resistance to the induction of apoptosis by treatment with GSH-DXR. On the other hand, endogenous Bax and overexpressed Flag-Bax were localized in the cytosolic fraction of HepG2 cells. Treatment of the cells with GSH-DXR caused translocation of Flag-Bax to the mitochondrial fraction following the induction of apoptosis. The induced apoptosis was enhanced by the expression of Flag-Bax. Moreover, Flag-Bax was partly located in the mitochondrial fraction in N52,66D-Bcl-xL-expressed cells without the induction of apoptosis. Therefore, the induction of apoptosis by treatment of HepG2 with GSH-DXR was enhanced, thereby facilitating the release of cytochrome c by both deamidated inactivation of Bcl-xL and functional translocation of Bax to the mitochondria via JNK activation. Deamidation of Bcl-xL might be induced in order to translocate Bax to the mitochondria.
引用
收藏
页码:389 / 395
页数:7
相关论文
共 62 条
  • [1] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [2] Adler V, 2004, ANN CLIN LAB SCI, V34, P35
  • [3] Regulation of JNK signaling by GSTp
    Adler, V
    Yin, ZM
    Fuchs, SY
    Benezra, M
    Rosario, L
    Tew, KD
    Pincus, MR
    Sardana, M
    Henderson, CJ
    Wolf, CR
    Davis, RJ
    Ronai, Z
    [J]. EMBO JOURNAL, 1999, 18 (05) : 1321 - 1334
  • [4] Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria
    Antonsson, B
    Montessuit, S
    Lauper, S
    Eskes, R
    Martinou, JC
    [J]. BIOCHEMICAL JOURNAL, 2000, 345 : 271 - 278
  • [5] Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells
    Antonsson, B
    Montessuit, S
    Sanchez, B
    Martinou, JC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) : 11615 - 11623
  • [6] Caspase-3 activation during apoptosis caused by glutathione-doxorubicin conjugate
    Asakura, T
    Sawai, T
    Hashidume, Y
    Ohkawa, Y
    Yokoyama, S
    Ohkawa, K
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) : 711 - 715
  • [7] Chemotherapeutic agents that induce mitochondrial apoptosis
    Asakura, T
    Ohkawa, K
    [J]. CURRENT CANCER DRUG TARGETS, 2004, 4 (07) : 577 - 590
  • [8] Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells
    Asakura, T
    Hashizume, Y
    Tashiro, K
    Searashi, Y
    Ohkawa, K
    Nishihira, J
    Sakai, M
    Shibasaki, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) : 171 - 177
  • [9] Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells
    Asakura, T
    Takahashi, N
    Takada, K
    Inoue, T
    Ohkawa, K
    [J]. ANTI-CANCER DRUGS, 1997, 8 (02) : 199 - 203
  • [10] Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells
    Asakura, T
    Ohkawa, K
    Takahashi, N
    Takada, K
    Inoue, T
    Yokoyama, S
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (10) : 1333 - 1337